Overview
Pinealon (EDR) is a synthetic short-chain tripeptide bioregulator designed specifically to support the brain, central nervous system, and cognitive longevity.
What problem it targets: It targets brain fog, poor memory retention, mental fatigue, age-related cognitive decline, traumatic brain injury recovery, and sleep-wake cycle disruption.
What It Does
• Restores neuronal protein synthesis: Penetrates the blood-brain barrier and cell nuclei to interact with DNA, stimulating the synthesis of essential structural and functional brain proteins.
• Exerts potent neuroprotection: Protects cortical neurons against hypoxia, oxidative stress, and free radical damage, preventing premature neuronal apoptosis.
• Optimizes cognitive stamina and focus: Enhances neurotransmitter efficiency and mental processing speed during intense psychological or intellectual stress.
• Realistic expectations: Administered in short 10- to 20-day cycles a few times per year. Enhances mental clarity and focus without the jitters, crashes, or addiction risks of classic stimulants.
Reconstitution
| Vial size | BAC water / Solvent | Concentration |
|---|---|---|
| 5 mg | + 2.5 mL | 2 mg/mL |
| 10 mg | + 5 mL | 2 mg/mL |
Protocol
| Phase | Frequency | Dose | Units (2 mg/mL) | Notes |
|---|---|---|---|---|
| Course (10–20 days) | Daily | 1–2 mg SubQ (up to 10 mg) | 50–100u | SubQ, daytime. Some protocols run higher single doses. |
| Between courses | – | – | – | 1–3 courses per year. Cycle: 10–20 day course, 1–3×/year. Timing: daytime (may be mildly activating). Note: brain-targeted bioregulator; evidence is largely Russian research. By sex: Unisex peptide bioregulator, short courses, no sex-specific dosing; minimal human data. Avoid in pregnancy. |
